TD downgrades Milestone Pharmaceuticals, suspends target on Etripamil uncertainty

Go back to TD downgrades Milestone Pharmaceuticals, suspends target on Etripamil uncertainty
(NASDAQ: MIST) Delayed: 1.17 +0.03 (2.63%)
Previous Close $1.14    52 Week High
Open $1.14    52 Week Low
Day High $1.18    P/E N/A 
Day Low $1.14    EPS
Volume 138,366